High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: A randomized, multicenter trial

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3653-3660

  Mauras, Nelly ^a,a   Attie, Kenneth M ^d   Reiter, Edward O ^b   Saenger, Paul ^c   Baptista, Joyce ^d   August, Gilbert P ^e   Bell, Jennifer J ^f   Foley Jr , Thomas P ^g   Gotlin, Ronald W ^h   Harbison, Madeleine D ⁱ   Hintz, Raymond L ^j   Hopwood, Nancy J ^k   MacGillivray, Margaret H ^l   Moore, Wayne V ^m   Moshang, Thomas ⁿ   Parker, Katrina L ^o   Plotnick, Leslie P ^p   Rogol, Alan D ^q   Russell, William E ^r   Styne, Dennis M ^s   Wilson, Thomas A ^t   Wyatt, David T ^u   more..

^a NEMOURS CHILDREN S CLINIC   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d GENENTECH INC   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f New York Presbyterian Hospital Columbia University Medical Center   (United States)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^h CHILDREN S HOSPITAL   (United States)

ⁱ WEILL CORNELL MEDICAL CENTER   (United States)

^j STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^l CHILDREN S HOSPITAL OF BUFFALO   (United States)

^m CHILDREN S MERCY HOSPITAL   (United States)

ⁿ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^o UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^p JOHNS HOPKINS HOSPITAL   (United States)

^q UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^r VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t STONY BROOK UNIVERSITY   (United States)

^u Midwest Athletes Against Childhood Cancer Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ANKLE EDEMA; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE SUBSTITUTION; HUMAN; HYPOGLYCEMIA; MALE; MULTICENTER STUDY; MYALGIA; NOSE MALFORMATION; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0033762860     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.10.3653     Document Type: Article

References (38)

1. Elevated growth hormone secretory rate in premature infants: Deconvolution analysis of pulsatile growth hormone secretion in the neonate
2. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys
3. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
4. Relationship between age, percentage body fat, fitness and 24h GH release in healthy young adults: Effects of gender
5. Regulatory mechanisms of growth hormone secretion are sexually dimorphic
6. Spontaneous growth hormone secretion increases during puberty in normal girls and boys
7. Augmentation of growth hormone secretion during puberty: Evidence for a pulse amplitude-modulated phenomenon
8. Specific time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of GH, FSH and LH in prepubertal girls with Turner's syndrome
9. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome
10. The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males
11. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (GH)-IGF-I axis in the human: Evidence from pubertal pathophysiology and sex steroid hormone replacement
12. Estrogen receptor blockade with tamoxifen diminishes GH secretion in boys: Evidence of a stimulatory role of endogenous estrogens during male adolescence
13. Clinical longitudinal standards for height and height velocity for North American children
14. Linear growth as a function of age at onset of puberty and sex steroid dosage: Therapeutic implications
15. Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism
16. Growth-hormone deficiency in man: An isolated recessively inherited defect
17. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children
18. Optimizing growth hormone therapy during puberty
19. Growth hormone increases rate of pubertal maturation
20. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group
21. Effect of long-term recombinant growth hormone therapy in children: The National Cooperative Growth Study, USA, 1985-1994
22. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty
23. Adult height in short normal adolescent girls treated with GnRHa and GH
24. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: Preliminary results
25. Adult height in 24 patients treated for GH deficiency and early puberty
26. Final height after combined growth hormone and gonadotropin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty
27. Height prognosis of children with true precocious puberty and growth hormone deficiency: Effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone
28. Radioimmunoassay of somatomedin C/insulin-like growth factor I
29. New approaches for interpreting projected bone densitometry data
30. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls
31. Management of growth hormone deficiency through puberty
32. The effects of growth hormone therapy on spontaneous sexual development
33. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
34. IGF-I physiology and breast cancer
35. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
36. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass
37. GH therapy in adults and children